DeutschNewstral
Article
bizjournals.com on 2021-08-03 20:02
Following $105M raise, St. Louis biotech startup Arch Oncology adds 3 execs to C-suite
Related news
- St. Louis biotech startup Arch Oncology raises $105M in Series C fundingbizjournals.com
- St. Louis biotech startup Arch Oncology expands C-suite with new hirebizjournals.com
- St. Louis biotech startup Arch Oncology names new CEObizjournals.com
- What's next for startup Arch Oncology and its cancer-fighting drug after raising $105Mbizjournals.com
- St. Louis startup Arch Oncology to partner with pharmaceutical giant Merck on lead drug candidatebizjournals.com
Rising trends in biotech oncology in IsraelThe Jerusalem Post (JPost.com)
Oncology dealmaking fuels biotech M&Ajdsupra.com- Remaining shares in Houston biotech co. scooped up for $105Mbizjournals.com
- Waltham oncology biotech grows as drugs move towards marketbizjournals.com
- FPfizer to buy oncology biotech in $2.3bn dealft.com
- Wisconsin company acquires Arizona biotech startup to boost oncology businessbizjournals.com
- GlaxoSmithKline to buy California biotech firm Sierra Oncology for $1.9Bbizjournals.com
- St. Paul biotech startup IGF Oncology names new CEObizjournals.com
- Female biotech execs shocked by models invited to biotech partybizjournals.com
- Rackspace hires new C-Suite execsbizjournals.com
- Arch Angels take stake in Minneapolis biotech startupbizjournals.com
- Arch Venture, biotech alums raise $800M for manufacturing startupbizjournals.com
- Seattle hasn't lost its appeal with biotech execs — sorry Bothellbizjournals.com
The Biotech IPO Boom Will Continue, Nasdaq Execs PredictForbes- Arizona biotech firm execs agree to pay cutbizjournals.com